Health After Birth Intervention Trial

NCT ID: NCT05137691

Last Updated: 2022-10-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

3 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-19

Study Completion Date

2022-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial is to assess the feasibility of a larger, definitive RCT and determine the clinical effectiveness of an NHS 1:1 programme versus a modified programme with a low carbohydrate dietary intervention (as per Feinman and colleagues classification) with telehealth, physical activity and enhanced behaviour change on specified health outcomes amongst post-partum women living with obesity

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

For individuals living with obesity, the post-partum period is currently the initial, optimal timeframe for weight management. Many women reconceive during the post-partum phase, increasing the risk of between-pregnancy bodyweight retention and even gain. Consequentially, many re-enter subsequent pregnancies with a higher BMI often associated with unfavourable obstetric outcome and further cyclical perpetuation.

Health behaviour change is an important facet within weight management interventions and delivery may be enhanced by digital technologies, for example, telehealth. Short messaging service (SMS) may be used to enhance communication between patients and practitioner and is relatively inexpensive to use.

Low carbohydrate diets continue to gain traction however research is arguably confounded by the lack of a universally agreed definition and classification. Feinman and colleagues (2015) propose intermediary categories. The experimental arm of this trial will be encouraged to adopt a non-ketogenic LCD as per Feinman.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Feasibility Randomised Controlled Trial
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

Adapted NHS weight management 1:1 programme. Low carbohydrate dietary focus, enhanced behaviour change via telehealth, daily step target supported by pedometers

Group Type EXPERIMENTAL

Adapted NHS weight management 1:1 programme

Intervention Type OTHER

Adapted NHS 1:1 weight management programme with a low carbohydrate dietary focus, incorporating enhanced behaviour change via telehealth, step count and pedometer

Active comparator NHS 1:1 weight management programme

12 week NHS 1:1 weight management programme

Group Type ACTIVE_COMPARATOR

NHS 1:1 weight management programme

Intervention Type OTHER

NHS 1:1 weight management programme

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adapted NHS weight management 1:1 programme

Adapted NHS 1:1 weight management programme with a low carbohydrate dietary focus, incorporating enhanced behaviour change via telehealth, step count and pedometer

Intervention Type OTHER

NHS 1:1 weight management programme

NHS 1:1 weight management programme

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult aged 18 or above
* Ready and motivated to make lifestyle changes
* Have a Body Mass Index of ≥30 kg/m2 (at initial booking appointment)

Additional study specific criteria

* English speaking and ability to read English language
* Capacity to consent to participating in the study
* Are non-diabetic or those with Type 2 diabetes which is diet controlled
* Deemed medically fit by GP/medical professional to participate via email
* Have recently given birth (within 1 year)
* Are not receiving weight management support elsewhere e.g. NHS, Scottish slimmers, weight watchers
* Have access to a mobile phone and weighing scales

Exclusion Criteria

* Have uncontrolled hypothyroidism
* Have unstable psychosis or severe and unstable personality disorder
* Are pregnant
* Have dementia
* Have moderate to severe learning disability or learning difficulty which impairs the ability to adhere to the programme (identified by medical history and confirmed with GP)
* Current alcohol or substance misuse (6 month period of abstinence)
* Active purging
* Bulimia Nervosa
* Binge Eating Disorder

Additional study specific criteria

* Known cancers
* Type 1 Diabetes or Type 2 Diabetes on any Diabetic medication (including Insulin)
* Have a pacemaker
* Renal impairment
* Taking Orlistat or any other weight loss medication or had previous bariatric surgery
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NHS Lothian

OTHER_GOV

Sponsor Role collaborator

Queen Margaret University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ashleigh Graham

Senior Practitioner in clinical research and Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ashleigh Graham

Role: PRINCIPAL_INVESTIGATOR

Queen Margaret University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Astley Ainslie Hospital

Edinburgh, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10052021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OBEAT - Beating Obesity
NCT03854331 COMPLETED NA